Company intelligence / Profile preview

Hindustan

Hyderabad, Telangana, Indiahindustantimes.com ↗

Ownership: Private
Development stage: Other

Overview

Hindustan Bio Sciences Limited has world-class manufacturing facilities for various dosage forms. It successfully developed and clinically trialed a recombinant human erythropoietin product for nephrology use. The company now markets this drug along with a broad range of pharmaceuticals globally.

Therapeutic areas: Nephrology
Modalities: Recombinant proteinSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Hindustan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hindustan.

Explore the full profile